Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Interventional Cardiologists (US)(?)

Council Members in this Study Group: 439

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Rohit Arora, MD
Professor of Medicine
Finch University of Health Science-Chicago Medical School

Rohit Arora, MD, FACC, FAHA, FASCI, FACP, is a Professor of Medicine and Professor of Physiology and Biophysics at Chicago Medical School, Illinois. He is also the Chairman of Cardiology and Associate Chairman of Medicine in the Department of Medicine. Dr. Arora is also Chief of Cardiology at the North...

Samuel Butman, MD, Interventional Cardiologist, Verde Valley Heart LLCSamuel Butman, MD
Interventional Cardiologist
Verde Valley Heart LLC

Samuel Butman, MD, is an Interventional Cardiologist at Verde Valley Medical Center. Dr. Butman is also a Clinical Associate Professor of Medicine at University Medical Center in Tucson, Arizona. He has also served as the Director of Cardiology Interventional Fellows Program and Director of Cardiac...

Paul Gurbel, MD
Director of Cardiovascular Research
Sinai Hospital of Baltimore Inc

Paul Gurbel, MD, is Director of Cardiovascular Research at the Center for Thrombosis Research at Sinai Hospital of Baltimore. Dr. Gurbel has authored over 100 peer-reviewed papers related primarily to coronary thrombosis and interventional cardiology. His particular expertise is in translational platelet...

Ramin Ebrahimi, MD
Director of Cardiac Catheterization Lab
Wadsworth VA Medical Center

Ramin Ebrahimi, MD, is Associate Clinical Professor at the University of California in Los Angeles. He is also Director of the Cardiac Catheterization Laboratory and Assistant Director of Nuclear Cardiology at the Wadsworth VA Medical Center. Dr. Ebrahimi’s clinical and research interests focus on interventional...

Jesse Sethi
Cardiologist/ Electrophysiologist
Cardiac Solutions

Jesse Sethi, MD, FACC, is a Cardiologist and Electrophysiologist at Cardiac Solutions, a private practice in Arizona. Dr. Sethi has expertise in electrophysiology procedures such as pacemakers, defibrillators (ICDs), biventricular ICDs, cardiac resynchronization therapy (CRT), atrial and ventricular...

Daniel Simon, MD
Division Chief of Cardiovascular Medicine
UNIVERSITY HOSPITAL - Case Medical Center

Daniel Simon, MD, is Division Chief of Cardiovascular Medicine, Director of the Heart and Vascular Institute at the University Hospitals Case Medical Center, and Herman K. Hellerstein Professor of Cardiovascular Research at the Case Western Reserve University School of Medicine. He graduated summa cum...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

The Endeavour stent appears to have a higher restenosis rate than currently marketed Drug Eluting Stents without the improved safety profile claimed by the company.  This finding is at odds with the companies marketing message to cardiologists.  These studies, along with the introduction of...

Mechanical thrombectomy of the coronary arteries has becoming increasingly more common with the advent of simpler aspiration catheters.  Although its use in the setting of acute myocardial infarction is even more common, it is not routine.  Randomized data indicating its effect on clinical...

This is not a real life article. Physicians will titrate the dosage of beta blockers, not utilize a fixed dose. The AHA ACC guidelines still recommend beta blockers, but the guidelines do not specifiy a fixed dosage.

Acute myocardial infarction is caused by a clot in the artery that obstructs and quickly reduces blood flow to the artery. The best treatment for STEMI is rapid opening of the artery with angioplasty and stenting. The article is important since it shows that active removal of the clot prior to stenting...

It is well known that the addition of thiazide diuretic to ACEI or ARB treatment adds about 10 mm Hg reduction on top of the 10 mm Hg reduction provided by the ACEI or ARB agent.  It is expected that blocking renin in the renin angiotensin system with Tekturna would provide a similar result.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Partner
  • Owner

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Analytics


Generated at 2009-01-08T19:00:17.880